Innovative Stem Cell Technique Accelerates Creation of Microglia for Brain Research and Disease Modeling
Harvard researchers have developed a swift and efficient method to generate human microglia-like cells from stem cells, enabling advanced neurodegenerative disease research and therapeutic development.
A groundbreaking approach at Harvard University has enabled the rapid and efficient generation of human microglia-like cells from induced pluripotent stem cells (iPSCs). Microglia, vital immune cells in the brain accounting for about 10% of its cells, play essential roles in neuroinflammation, clearing debris, and supporting neural circuits. Dysfunction of microglia is linked to various neurodegenerative disorders such as Alzheimer's, Parkinson's, Huntington's disease, ALS, and multiple sclerosis.
Traditionally, obtaining human microglia is challenging due to the invasive biopsies required, and rodent microglia differ significantly from humans, complicating translational research. To overcome these hurdles, researchers at the Wyss Institute and Harvard Medical School led by George Church developed a novel system that reduces the differentiation process from 35 days to just four, saving time and resources.
This new method builds on the TFome™ platform, a comprehensive library of transcription factors (TFs) critical to cell fate determination. The team engineered TF libraries specific to microglia and screened different combinations to identify a potent six-TF cocktail capable of transforming iPSCs into microglia-like cells rapidly. These cells exhibited key genetic and functional similarities to primary human microglia, including responses to inflammatory stimuli and disease-related proteins like TDP-43.
Further refinement involved additional screening with a second set of TFs, resulting in a 6-TF cocktail that enhances microglia maturity and functionality. The cells demonstrated expected behavior when exposed to neuroinflammatory signals, such as interferon gamma, and pathogenic proteins associated with neurodegeneration, confirming their potential use in studying disease mechanisms.
The ability to produce microglia efficiently opens new avenues for brain disease research, drug discovery, and personalized medicine. This platform technology also holds promise for generating other difficult-to-isolate cell types, advancing the development of next-generation regenerative therapies. Overall, this innovation represents a significant step toward better understanding and treating neurological diseases.
Source: https://medicalxpress.com/news/2025-06-stem-cell-platform-aims-recreate.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Increasing Cases of Heat-Related Illnesses in Children
Rising summer temperatures are leading to increased heat-related illnesses among children, with more emergency visits and hospitalizations observed in recent years. This trend underscores the importance of prevention and awareness efforts to safeguard pediatric health amid climate change.
Ohio Couple Celebrates Birth of Baby from 31-Year-Old Frozen Embryo
A groundbreaking fertility achievement as an Ohio couple welcomes a baby from a nearly 31-year-old frozen embryo, setting a new record in reproductive medicine. Learn about this historic case and its implications for fertility technology.
The Risks of Chemotherapy Enzyme Deficiency and the Importance of Genetic Testing
A tragic case underscores the vital importance of genetic testing before chemotherapy to prevent fatal toxicity caused by enzyme deficiencies. Learn why personalized medicine is crucial in cancer treatment.
Impact of Healthcare Provider Bankruptcies on Patient Care and Safety
Healthcare provider bankruptcies in the U.S. are rising, leading to lower care quality and increased risks for vulnerable residents, especially in nursing homes. A Stanford study highlights the urgent need for policy interventions to protect patient safety.